Innovus Pharma Announces the Approval of its Product ProstaGorx in Canada for Benign Prostate Hyperplasia ("BPH")
04 juin 2018 14h46 HE
|
Innovus Pharmaceuticals, Inc.
ProstaGorx is the Ninth Innovus Pharma Product Approved in Canada to Date SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the...